MedPage Today on MSN
Among IL-1 Inhibitors for Treating VEXAS, This One Stands Out
Canakinumab (Ilaris) may be the better option than anakinra (Kineret) when treating the rare disease called VEXAS syndrome with an interleukin-1 (IL-1) inhibitor, a multinational study indicated.
On September 27, 2024, Rwanda reported an outbreak of Marburg virus disease (MVD), after a cluster of cases of viral hemorrhagic fever was detected at two urban hospitals. We report key aspects of the ...
Background Humanitarian emergencies increase the risk of development or exacerbation of mental health conditions. This study documents how mental health differs between younger and older adults to ...
Aim In the UK, pharmacological management of patients with heart failure (HF) occurs predominantly in general practice. Using ...
Introduction Safe surgical care is a cost-effective intervention for addressing a wide range of conditions, yet postoperative ...
Main outcome measures The main outcome was the type of injuries observed by international healthcare workers during the ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
Passive range of motion refers to range of motion when somebody or something else, such as a therapist or machine, is moving a body part or a joint, rather than the person themselves. Range of motion ...
BACKGROUND: Early detection of atrial fibrillation (AF) is essential for preventing ischemic stroke and other cardiovascular complications. However, the incidence and prognosis of AF in the general ...
Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results